Published in Bull World Health Organ on March 16, 2005
International Monetary Fund programs and tuberculosis outcomes in post-communist countries. PLoS Med (2008) 1.41
Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia. BMC Infect Dis (2011) 1.35
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res (2006) 1.19
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery. Bull World Health Organ (2007) 1.08
Resistance to implementing policy change: the case of Ukraine. Bull World Health Organ (2008) 1.05
Adherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya. PLoS One (2012) 1.04
Views of health service providers on obstacles to tuberculosis control in Ghana. Infect Dis Poverty (2013) 0.92
The health crisis in Russia. BMJ (2005) 0.84
Tuberculosis in Asia and the pacific: the role of socioeconomic status and health system development. Int J Prev Med (2012) 0.82
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
Carrots, sticks and tuberculosis. Thorax (1999) 2.43
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax (2005) 2.09
Tuberculous meningitis. J Neurol Neurosurg Psychiatry (2000) 2.05
Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med (1997) 1.95
AIDS and hepatitis B in the former Soviet Union. BMJ (1992) 1.65
Mycobacterium malmoense infection in HIV positive patients. J Infect (1991) 1.64
Reasons for increased incidence of tuberculosis. Audit suggests that undernotification is common. BMJ (1995) 1.55
Evaluation of strategies for molecular fingerprinting for use in the routine work of a Mycobacterium reference unit. J Clin Microbiol (1998) 1.55
Biology of oligotrophic bacteria. Annu Rev Microbiol (1979) 1.54
Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis (2003) 1.52
Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: analysis of notification data. Int J Tuberc Lung Dis (2005) 1.46
The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS (1993) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol (2002) 1.44
Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care (2009) 1.43
The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection. Eur Respir J (2006) 1.42
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis (2000) 1.42
Tuberculosis recommendations. Sex Transm Infect (1998) 1.40
Infectious osteitis pubis in an HIV seropositive female. Genitourin Med (1994) 1.40
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J (2005) 1.30
Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study. BMJ (2005) 1.24
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill (2013) 1.21
HIV testing strategies across European countries. HIV Med (2008) 1.21
Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis (2005) 1.21
Health service providers' perceptions of barriers to tuberculosis care in Russia. Health Policy Plan (2006) 1.20
Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. BMJ (1999) 1.19
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res (2006) 1.19
Stigma and HIV infection in Russia. AIDS Care (2006) 1.18
HIV and tuberculosis co-infection in an inner London hospital--a prospective anonymized seroprevalence study. J Infect (1999) 1.10
Molecular epidemiology of tuberculosis in England, 1998. Int J Tuberc Lung Dis (2009) 1.09
Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions. Eur J Public Health (2005) 1.07
Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J (2009) 1.07
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol (2004) 1.07
[Bacterial decomposition of ammonium perchlorate]. Mikrobiologiia (1976) 1.07
Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. Int J Tuberc Lung Dis (2003) 1.06
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. Int J Tuberc Lung Dis (2012) 1.05
Rapid onset of blindness due to meningeal carcinomatosis from an oesophageal adenocarcinoma. Postgrad Med J (1991) 1.05
Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol (2000) 1.04
The molecular epidemiology of tuberculosis in inner London. Epidemiol Infect (2002) 1.03
A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example. Eur J Public Health (2004) 1.02
Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia. Lancet (1992) 1.02
Physicians' experience and survival in patients with AIDS. N Engl J Med (1996) 1.02
Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study. Eur J Clin Microbiol Infect Dis (2011) 1.01
Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings. J Clin Microbiol (2011) 0.99
Tuberculosis and HIV seroprevalence in Lambeth, Southwark and Lewisham, an area of South London. Respir Med (2003) 0.98
Fatal haemorrhage following liver biopsy in patients with HIV infection. Genitourin Med (1996) 0.98
Multidrug resistance emerging in North London outbreak. Thorax (2006) 0.98
Could a tuberculosis epidemic occur in London as it did in New York? Emerg Infect Dis (2000) 0.96
Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut (1997) 0.95
Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. Clin Oncol (R Coll Radiol) (1994) 0.95
Human microsporidiosis in African AIDS patients with chronic diarrhea. J Infect Dis (1995) 0.95
Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis (2002) 0.95
Multiple drug resistant tuberculosis: aetiology, diagnosis and outcome. Br Med Bull (1998) 0.94
Rapid detection of multidrug-resistant tuberculosis. Eur Respir J (1997) 0.92
MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus. Int J Tuberc Lung Dis (2010) 0.90
Cryptococcal infection in AIDS. Int J STD AIDS (1992) 0.90
Post-exposure prophylaxis following non-occupational exposure to HIV: risks, uncertainties, and ethics. Int J STD AIDS (2000) 0.89
Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS. Thorax (1993) 0.88
Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data. Int J Tuberc Lung Dis (2005) 0.88
HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients. Clin Exp Immunol (1994) 0.87
Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels. J Infect (1991) 0.87
[Water microflora studied by electron microscopy]. Mikrobiologiia (1969) 0.86
Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Thorax (2009) 0.85
AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung. Thorax (1995) 0.85
Mycobacterium kansasii and human immunodeficiency virus co-infection in London. J Infect (1998) 0.85
Knowledge and attitudes to HIV and AIDS and sexual practices among university students in Lusaka, Zambia and London, England: are they so different? J R Soc Health (1997) 0.85
[Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region]. Probl Tuberk Bolezn Legk (2005) 0.84
Empyema thoracis in AIDS. J R Soc Med (1994) 0.84
Extrapulmonary pneumocystosis. Ann Intern Med (1991) 0.84
Drug resistance is not the principal barrier to effective control of tuberculosis in Zambia. J Infect Dis (1994) 0.83
Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysis. Health Policy Plan (2006) 0.83
Septata intestinalis: a new microsporidian in Africa. Lancet (1994) 0.83
Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax (1995) 0.82
The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge. Vaccine (2012) 0.82
Laboratory diagnosis of paediatric tuberculosis in the European Union/European Economic Area: analysis of routine laboratory data, 2007 to 2011. Euro Surveill (2014) 0.82
Mucosa-associated gastric lymphoma occurring in an HIV-antibody-positive patient. AIDS (1992) 0.80
Rapidly evolving HIV-1 infection in lung of AIDS patient. Lancet (1994) 0.80
Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support. Public Health (2005) 0.79
Endogenous Candida endophthalmitis. J R Soc Med (1993) 0.79
Compulsory detention of recalcitrant tuberculosis patients in the context of a new tuberculosis control programme in Israel. Public Health (2004) 0.79